Patil Jayaditya Devpal, Mohamed Yusuf Mahdi, AlMarzooq Raed
Obstetrics and Gynaecology, University Hospitals of Leicester NHS Trust, Leicester, GBR.
Emergency Medicine, Salmaniya Medical Complex, Manama, BHR.
Cureus. 2023 May 4;15(5):e38522. doi: 10.7759/cureus.38522. eCollection 2023 May.
Introduction Colorectal cancer (CRC) management has advanced globally, leading to a steady decline in mortality rates. However, recent studies have shown that the prognosis of CRC varies based on the anatomical site of the primary tumor, histopathological grading, and type of mutation. With an increase in the incidence of CRC globally and in Bahrain, there is a need for a recent descriptive study to improve overall management. This study aims to investigate the anatomical, histopathological, and molecular prognostic factors in CRC patients presenting to the Salmaniya Medical Complex (SMC). Methods The study was conducted retrospectively using ISEHA electronic database over two years (January 2019 to December 2020). A total of 101 patients with primary CRC registered in the General Surgery Department were included in this study. The sample size was further stratified and analyzed using descriptive statistics based on the available data of measured outcomes. Results Anatomical data showed that 65% of CRC patients had a tumor on the left side of the colon, 27.7% on the right side, and 7% in the transverse colon. Overall, 16.8% of all patients had rectal involvement. Histopathological data showed that 86% of the patients had a low-grade CRC adenocarcinoma. The most diagnosed tumor stage was pT3N0M0 (22.8%). In addition, there were ten metastatic cases (10 to the liver, of which three had concomitant lung involvement and two had concurrent brain metastases). The average tumor diameter was 46.2 mm, where 63% ranged between 30 mm to 69 mm. Most mutations involved the (27.7%) and the (29%) genes. Conclusion The study found that majority of CRC patients at SMC in Bahrain had relatively good overall anatomical, tumor staging and grading prognostic factors but somewhat poorer molecular prognostics.
引言 全球范围内,结直肠癌(CRC)的治疗取得了进展,死亡率稳步下降。然而,最近的研究表明,CRC的预后因原发肿瘤的解剖部位、组织病理学分级和突变类型而异。随着全球及巴林CRC发病率的上升,需要开展一项最新的描述性研究以改善整体治疗。本研究旨在调查就诊于萨勒曼尼亚医疗中心(SMC)的CRC患者的解剖学、组织病理学和分子预后因素。
方法 本研究采用ISEHA电子数据库进行了为期两年(2019年1月至2020年12月)的回顾性研究。本研究纳入了普通外科登记的101例原发性CRC患者。根据测量结果的可用数据,使用描述性统计方法对样本量进行进一步分层和分析。
结果 解剖学数据显示,65%的CRC患者肿瘤位于结肠左侧,27.7%位于右侧,7%位于横结肠。总体而言,所有患者中有16.8%有直肠受累。组织病理学数据显示,86%的患者患有低级别CRC腺癌。最常见的肿瘤分期为pT3N0M0(22.8%)。此外,有10例转移病例(10例转移至肝脏,其中3例伴有肺受累,2例伴有脑转移)。肿瘤平均直径为46.2mm,其中63%在30mm至69mm之间。大多数突变涉及(27.7%)和(29%)基因。
结论 该研究发现,巴林SMC的大多数CRC患者在解剖学、肿瘤分期和分级方面的总体预后因素相对较好,但分子预后因素略差。